Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia
Background: Recent studies suggest that sustained use of generic antibiotics may be associated with clinical failure and emergence of antibacterial resistance. The present study was designed to determine the clinical outcome between the use of generic meropenem (GM) and brand-name meropenem (BNM). A...
Main Authors: | Karen Ordóñez, Max M. Feinstein, Sergio Reyes, Cristhian Hernández-Gómez, Christian Pallares, María V. Villegas |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-07-01
|
Series: | Brazilian Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1413867019301680 |
Similar Items
-
Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
by: Ping Yang, et al.
Published: (2021-09-01) -
Is Brand Name Best? Brand name versus generic pharmaceuticals in clinical practice
by: Andrea Bakker
Published: (2017-06-01) -
Name Brand and Generic Brand Competition:An analysis of Generic Brand Strategy of Market and Channel Investment Portfolio
by: Tyng-Yu Liou, et al.
Published: (2013) -
Generic Drugs : Physician Prescribing Practices for Brand Name and Generic Medications
by: George, Tamuno Raymond
Published: (2016) -
North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
by: Malvankar-Mehta MS, et al.
Published: (2019-12-01)